What Is Driving Hologic's Strength in the US Diagnostics Market?

HOLX's Diagnostics gains accelerate as U.S. molecular testing drives growth and new Panther Fusion and Genius platform approvals widen its runway.

Zacks Investment Research • Dec 12, 2025

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks Investment Research • Dec 12, 2025

HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?

Hologic shares rise 16% in six months, with divisional strength clinical data and a go-private deal shaping the short-term outlook.

Zacks Investment Research • Dec 8, 2025

Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions

HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.

Zacks Investment Research • Dec 4, 2025

Why Is Hologic (HOLX) Up 1% Since Last Earnings Report?

Hologic (HOLX) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Dec 3, 2025

New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test.

Business Wire • Dec 2, 2025

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Investment Research • Dec 1, 2025

HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?

DGX's strong YTD gains and momentum in advanced diagnostics and acquisitions highlight why it may stand out in the competitive testing market against HOLX.

Zacks Investment Research • Nov 27, 2025

New Clinical Evidence Bolsters Hologic's Breast Cancer Technologies

HOLX is set to present new real-world data at RSNA 2025, showing how its AI-driven breast imaging tools boost workflow without sacrificing detection.

Zacks Investment Research • Nov 26, 2025

Here's Why Hologic (HOLX) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Nov 26, 2025